Exact Sciences
EXAS
#1165
Rank
A$27.78 B
Marketcap
A$145.54
Share price
0.00%
Change (1 day)
81.98%
Change (1 year)
Exact Sciences Corp. is a molecular diagnostics company with an initial focus on the early detection and prevention of colorectal cancer.

EPS for Exact Sciences (EXAS)

EPS in 2025 (TTM): A-$8.54

According to Exact Sciences's latest financial reports the company's current EPS (TTM) is A-$7.38. In 2024 the company made an earnings per share (EPS) of A-$7.73.

EPS history for Exact Sciences from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)A-$8.5410.51%
2024A-$7.73
2022A-$4.912.31%
2021A-$4.80-38.54%
2020A-$7.81692.96%
2019A-$0.98-50.69%
2018A-$2.0044%
2017A-$1.39-39.39%
2016A-$2.29-2.94%
2015A-$2.3637.1%
2014A-$1.7279.71%
2013A-$0.96-21.59%
2012A-$1.22

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Sanofi
SNY
A$2.86-138.82%๐Ÿ‡ซ๐Ÿ‡ท France
Veracyte
VCYT
A$1.17-115.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Antares Pharma
ATRS
A$0.47-106.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Myriad Genetics
MYGN
A-$6.01-18.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Biocept
BIOC
A-$70.61 856.77%๐Ÿ‡บ๐Ÿ‡ธ USA